Wellington Management Group LLP Pacira Bio Sciences, Inc. Transaction History

Wellington Management Group LLP

$529 Billion
Q2 2025

A detailed history of Wellington Management Group LLP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 545,602 shares of PCRX stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

545,602

Previous 537,130 1.58%

Holding current value

$13 Million

Previous $13.3 Million 2.31%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$22.91 - $27.14 $194,093 - $229,930	8,472 Added 1.58%	545,602 $13 Million
Q1 2025 May 13, 2025	BUY	$18.33 - $27.25 $9.85 Million - $14.6 Million	537,130 New	537,130 $13.3 Million
Q4 2024 Feb 12, 2025	BUY	$15.3 - $20.33 $237,792 - $315,968	15,542 Added 3.42%	470,191 $8.86 Million
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $380,086 - $924,551	-32,486 Reduced 6.67%	454,649 $6.85 Million
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $4.94 Million - $6.11 Million	193,903 Added 66.13%	487,135 $13.9 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $8.12 Million - $10.4 Million	293,232 New	293,232 $8.57 Million
Q4 2023 Feb 12, 2024	BUY	$26.32 - $34.31 $8.62 Million - $11.2 Million	327,606 New	327,606 $11.1 Million
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $3.79 Million - $4.95 Million	-123,440 Reduced 28.22%	313,910 $9.63 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $2.12 Million - $2.78 Million	58,572 Added 15.46%	437,350 $17.5 Million
Q1 2023 May 12, 2023	SELL	$35.53 - $43.38 $10.1 Million - $12.3 Million	-284,284 Reduced 42.87%	378,778 $15.5 Million
Q4 2022 Feb 13, 2023	SELL	$38.19 - $57.45 $11.2 Million - $16.9 Million	-294,006 Reduced 30.72%	663,062 $25.6 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $11 Million - $12.6 Million	214,079 Added 28.81%	957,068 $50.9 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $3.43 Million - $5.44 Million	66,624 Added 9.85%	742,989 $43.3 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $36.3 Million - $46.3 Million	605,370 Added 852.69%	676,365 $51.6 Million
Q4 2021 Feb 11, 2022	BUY	$47.97 - $62.21 $3.41 Million - $4.42 Million	70,995 New	70,995 $4.27 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $21.7 Million - $28.9 Million	-366,071 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$50.47 - $66.26 $382,714 - $502,449	-7,583 Reduced 2.03%	366,071 $21.9 Million
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $44,486 - $53,928	-856 Reduced 0.23%	373,654 $22.5 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $11.5 Million - $19.7 Million	374,510 New	374,510 $19.7 Million

Others Institutions Holding PCRX

# of Institutions

257

Shares Held

51.4M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.09B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Pacira Bio Sciences, Inc. Transaction History